NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Nutex Health Inc. for possible violations of federal securities laws and unlawful business practices following a short report by Blue Orca Capital that raised concerns about litigation risks associated with Nutex's relationship with a third-party vendor [1][2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is encouraging Nutex stockholders who have suffered losses to contact them to discuss their legal rights [1][4]. - The investigation is focused on whether Nutex has engaged in unlawful business practices, particularly in light of allegations made in the Blue Orca report [1][2]. Group 2: Stock Performance - Following the release of the Blue Orca report, Nutex's stock price experienced a significant decline, falling by $11.18 per share, or 10.05%, closing at $100.01 on July 22, 2025 [3].